Project Details
Description
This study will identify new pathways for both development of novel anti-atherosclerotic therapeutics and approaches to lowering the heightened cardiovascular (CV) risk associated with Clonal Haematopoiesis of Indeterminate Potential (CHIP). This will lead to future implementation trials of patients with CHIP mutations in CV prevention clinics.
| Status | Active |
|---|---|
| Effective start/end date | 1/06/22 → 31/05/25 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.